iWel — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

iWel Health is a private, pre-revenue biotech/digital health company founded in 2016, focusing on making CGM technology accessible for wellness and metabolic health management. The company is developing a disposable, smartphone-connected CGM device aimed at the large markets of weight loss (including GLP-1 users), prediabetes, and diabetes. Led by a seasoned medical device and pharmaceutical veteran, iWel is positioning itself in the competitive CGM landscape by emphasizing affordability and over-the-counter accessibility for non-traditional, consumer-led use cases.

Metabolic DiseaseDiabetesObesity

Technology Platform

Proprietary biosensing platform for continuous glucose monitoring (CGM). Features a disposable, ultra-compact, smartphone-connected device designed for over-the-counter wellness and metabolic health use.

Opportunities

The massive and growing markets for weight loss (especially with GLP-1 drugs), prediabetes, and metabolic wellness represent a largely untapped opportunity for an affordable, OTC CGM.

Successfully positioning the device as a consumer wellness tool could enable rapid direct-to-consumer and corporate wellness channel growth, bypassing slower traditional medical reimbursement pathways.

Risk Factors

Intense competition from established CGM giants and new digital health aggregators poses a major threat.

Achieving FDA clearance for an OTC CGM and proving consumer willingness to consistently pay out-of-pocket for wellness glucose data are significant regulatory and commercial risks.

As a pre-revenue company, securing adequate funding is a persistent challenge.

Competitive Landscape

iWel operates in a highly competitive space. It faces direct competition from medical CGM leaders Dexcom and Abbott in diabetes management, and from digital health/software companies like Signos, Levels, and January that provide analytics on top of existing CGMs for wellness. Its key differentiator is the development of its own low-cost hardware platform aimed at the OTC market.

More companies in Digital Health & Biotech SaaS →More companies in United States →